Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/psychosocial-dimensions-of-brca-testing-an-overshadowed-issue-VwU70h4hw6
References (35)
-
W. Burke, M. Daly, J. Garber, J. Botkin, M. Kahn, P. Lynch, A. McTiernan, K. Offit, Jeffrey Perlman, G. Petersen, E. Thomson, C. Varricchio (1997)
Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.JAMA, 277 12
-
M. Watson, S. Lloyd, R. Eeles, B. Ponder, D. Easton, S. Seal, D. Averill, P. Daly, W. Ormiston, V. Murday (1996)
Psychosocial impact of testing (by linkage) for the BRCA1 breast cancer gene: An investigation of two families in the research settingPsycho‐Oncology, 5
-
Anonymous (1997)
Mammography screening for ages 40-49 not supported by data, NIH panel says.The Cancer Letter, 23
-
C. Lerman, S. Narod, K. Schulman, C. Hughes, A. Gomez‐Caminero, G. Bonney, Karen Gold, B. Trock, D. Main, J. Lynch, C. Fulmore, C. Snyder, S. Lemon, T. Conway, P. Tonin, G. Lenoir, H. Lynch (1996)
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.JAMA, 275 24
-
C. Lerman, R. Croyle (1996)
Emotional and behavioral responses to genetic testing for susceptibility to cancer.Oncology, 10 2
-
F. Collins (1996)
BRCA1--lots of mutations, lots of dilemmas.The New England journal of medicine, 334 3
-
C. Lerman, M. Daly, A. Masny, A. Balshem (1994)
Attitudes about genetic testing for breast-ovarian cancer susceptibility.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 12 4
-
J. Struewing, P. Hartge, S. Wacholder, Sonya Baker, M. Berlin, M. McAdams, Michelle Timmerman, L. Brody, M. Tucker (1997)
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.The New England journal of medicine, 336 20
-
F. Visco, M. Skolnick (1996)
Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. CommentariesJournal of Clinical Oncology, 14
-
A. Wit, A. Tibben, P. Frets, E. Meijers-Heijboer, P. Devilee, M. Niermeijer (1996)
Males at–risk for the BRCA1‐1ene, the psychological impactPsycho‐Oncology, 5
-
R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, N. Collins, S. Gregory, C. Gumbs, G. Micklem, R. Barfoot, R. Hamoudi, Sandeep Patel, Catherine Rices, P. Biggs, Yasmin Hashim, Amanda Smith, F. Connor, A. Arason, J. Gudmundsson, David Flcenec, D. Kelsell, D. Ford, P. Tonin, P. Tonin, D. Bishop, N. Spurr, B. Ponder, R. Eeles, J. Peto, P. Devilee, C. Cornelisse, H. Lynch, S. Narod, S. Narod, G. Lenoir, V. Egilsson, Rosa Barkadottir, D. Easton, D. Bentley, P. Futreal, A. Ashworth, M. Stratton (1995)
Identification of the breast cancer susceptibility gene BRCA2Nature, 378
-
B. Healy (1997)
BRCA genes--bookmaking, fortunetelling, and medical care.The New England journal of medicine, 336 20
-
M. Richards (1996)
Lay and professional knowledge of genetics and inheritancePublic Understanding of Science, 5
-
Lerman (1996)
BRCA1 testing in families with hereditary breast-ovarian cancer.Journal of the American Medical Association, 275
-
Lynch (1997)
Genetic susceptibility testing: a therapeutic illusion?: Reply.Cancer, 79
-
S. Nesnow, L. Triplett, T. Slaga (1984)
Tumor initiating activities of 1-nitropyrene and its nitrated products in SENCAR mice.Cancer letters, 23 1
-
J. Green (1989)
Counselling for HIV infection and AIDS: the past and the future.AIDS care, 1 1
-
A. Patenaude, K. Schneider, S. Kieffer, K. Calzone, J. Stopfer, Laura Basili, B. Weber, J. Garber (1996)
Acceptance of invitations for p53 and BRCA1 predisposition testing: Factors influencing potential utilization of cancer genetic testingPsycho‐Oncology, 5
-
H. Sobol, D. Birnbaum, F. Eisinger (1994)
Evidence for a third breast-cancer susceptibility geneThe Lancet, 344
-
Y. Miki, J. Swensen, D. Shattuck-Eidens, P. Futreal, K. Harshman, S. Tavtigian, Qingyun Liu, C. Cochran, L. Bennett, W. Ding, R. Bell, J. Rosenthal, C. Hussey, Thanh Tran, M. Mcclure, C. Frye, T. Hattier, R. Phelps, A. Haugen-Strano, H. Katcher, Kazuko Yakumo, Z. Gholami, Daniel Shaffer, S. Stone, Steven Bayer, Christian Wray, R. Bogden, P. Dayananth, J. Ward, P. Tonin, S. Narod, Pamela Bristow, F. Norris, L. Helvering, P. Morrison, P. Rosteck, Mei Lai, J. Barrett, C. Lewis, S. Neuhausen, L. Cannon-Albright, D. Goldgar, R. Wiseman, A. Kamb, M. Skolnick (1994)
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.Science, 266 5182
-
American Society for Clinical Oncology (1996)
Statement of the American Society of Clinical Oncology: Genetic Testing for Cancer Susceptibility.Journal of Clinical Oncology, 14
-
Burke (1997)
Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II: Brca1 and BRCA2.Journal of the American Medical Association, 277
-
Henry Lynch, P. Watson, T. Conway, J. Lynch, Sue Slominski‐Caster, S. Narod, Jean Feunteun, Gilbert Lenoir (1993)
DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.Archives of internal medicine, 153 17
-
Kash (1995)
Psychological counselling strategies for women at risk of breast cancer.Journal of the National Cancer Institute Monograph, 17
-
H. Lynch, S. Lemon, C. Durham, S. Tinley, Chris Connolly, J. Lynch, Jonathan Surdam, Ernest Orinion, Sue Slominski‐Caster, P. Watson, C. Lerman, P. Tonin, Gilbert Lenoir, O. Serova, S. Narod (1997)
A descriptive study of BRCA1 testing and reactions to disclosure of test resultsCancer, 79
-
Struewing (1995)
Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.Cancer Epidemiology and Biomarkers Prev, 4
-
R. Eeles, T. Cole, R. Taylor, P. Lunt, M. Baum (1996)
Prophylactic mastectomy for genetic predisposition to breast cancer: the proband's story.Clinical oncology (Royal College of Radiologists (Great Britain)), 8 4
-
Dudok de Wit (1996)
Males at risk for the BRCA1 gene: the psychological impact.Psycho-Oncology, 5
-
C. Julian-reynier, F. Eisinger, P. Vennin, F. Chabal, Y. Aurran, C. Noguès, Y. Bignon, M. Machelard-Roumagnac, C. Maugard-Louboutin, D. Serin, B. Blanc, P. Orsoni, H. Sobol (1996)
Attitudes towards cancer predictive testing and transmission of information to the family.Journal of Medical Genetics, 33
-
P. Vennin, S. Giard, C. Julian-reynier, F. Sailly, J. Peyrat, C. Fournier, F. Eisinger, H. Sobol (1996)
[Attitudes towards screening and prevention of breast and ovarian cancers with hereditary predisposition. Survey by female gynecologists in the north of France].Bulletin du cancer, 83 9
-
H. Chaliki, S. Loader, J. Levenkron, W. Logan-Young, W. Hall, P. Rowley (1995)
Women's receptivity to testing for a genetic susceptibility to breast cancer.American journal of public health, 85 8 Pt 1
-
K. Birmingham (1997)
Insurers admit genetic discriminationNature Medicine, 3
-
F. Couch, Michelle Deshano, M. Blackwood, K. Calzone, J. Stopfer, Lisa Campeau, A. Ganguly, T. Rebbeck, B. Weber, L. Jablon, M. Cobleigh, K. Hoskins, J. Garber (1997)
BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.The New England journal of medicine, 336 20
-
M. Ponder, J. Green (1996)
BRCA1 testing: Some issues in moving from research to servicePsycho‐Oncology, 5
-
Committee of the Health Council of the Netherlands (1994)
Hereditary: science and society on the possibilities and limits of genetic testing and gene therapy.Human Gene Therapy, 5
- Publisher
- Wiley
- Copyright
- 2001 Blackwell Science Ltd
- ISSN
- 0961-5423
- eISSN
- 1365-2354
- DOI
- 10.1046/j.1365-2354.2001.00254.x
- Publisher site
- See Article on Publisher Site
Abstract
Routine cancer susceptibility testing will soon be feasible in clinical practice. However, to date, this new technology has entailed many limitations, including potential adverse psychosocial consequences. Empirical studies examining these psychosocial aspects are strikingly scarce, especially in continental European countries. Are we prepared for managing the psychosocial problems that emerge from widespread introduction of this practice? Current research do not take into account cross‐cultural variations in attitudes and reactions towards genetic testing. This paper points to the urgent need for obtaining a more accurate picture on the psychosocial aspects of breast cancer gene testing and disclosure in order to design recommendations for implementation in populations with highly variable cultural and legal background.
Journal
European Journal of Cancer Care – Wiley
Published: Jun 1, 2001